Lodosyn (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Lodosyn drug offered from Avera McKennan Hospital. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: carbidopa
SUBSTANCE NAME: CARBIDOPA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-11-13
END MARKETING DATE: 0000-00-00


Lodosyn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLodosyn from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2015-11-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0711_17f28a82-4db0-4ba5-93eb-4e55cc7de57e
PRODUCT NDC: 69189-0711
APPLICATION NUMBER: NDA017830

Other CARBIDOPA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Carbidopa Tablets, 25 mg
Amerigen Pharmaceuticals Inc.Carbidopa
Aton Pharma, IncLodosyn
Avera McKennan HospitalLodosyn
Edenbridge Pharmaceuticals LLCCarbidopa
Ingenus Pharmaceuticals NJ, LLCCARBIDOPA
KAISER FOUNDATION HOSPITALSLODOSYN
Oceanside PharmaceuticalsCarbidopa